Hypertension During Intravenous Immune Globulin Infusion for Kawasaki’s Disease

Abstract

Get full access to this article

View all access options for this article.

References

Feldmeyer

Brenden

Haile

. Not all intravenous immunoglobulin preparations are equally well tolerated. Acta Derm Venereol. 2010;90:494-497.

Katz

Achiron

Sherer

Shoenfeld

. Safety of immunoglobulin (IVIG) therapy. Autoimmun Rev. 2007;6:257-259.

Sherer

Levy

Langevitz

Rauova

Fabrizzi

Shoenfeld

. Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases. Pharmacology. 2001;62:133-137.

Keohane

Kavanagh

Gordon

Hunter

JAA

. Transient hypertension during infusion of intravenous gammaglobulin for dermatomyositis. J Dermatol Treat. 1999;10:287-288.

Hughes

Donofrio

Bril

; ICE Study Group. Intravenous immune globulin (10% caprylatechroma-tography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomized placebo-controlled trial. Lancet Neurol. 2008;7:136-144.

Donofrio

Bril

Dalakas

; ICE Study Group. Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculopathy. Arch Neurol. 2010;67:1082-1088.

Immune Globulin. In: DRUGDEX® System [Internet database]. Greenwood Village, CO: Thomson Reuters (Healthcare). Accessed September 2, 2012.

Bentley

Rosso

Sadnicka

Israeli-Korn

Laffan

Sharma

. Intravenous immunoglobulin increases plasma viscosity without parallel rise in blood pressure. J Clin Pharm Ther. 2012;37:286-290.

Caress

Kennedy

Eickman

. Safety of intravenous immunoglobulin treatment. Expert Opin Drug Saf. 2010;6:971-979.

10.

Orbach

Katz

Sherer

Shoenfeld

. Intravenous immunoglobulin: adverse effects and safe administration. Clin Rev Allergy Immunol. 2005;29:173-184.